{"id":"https://openalex.org/W4405038686","doi":"https://doi.org/10.1182/blood-2024-198928","title":"Personalized Oral Maintenance Therapy with Decitabine/Cedazuridine (ASTX727) Combined with a Molecularly Targeted Agent (Venetoclax, Gilteritinib, Ivosidenib, or Enasidenib) in Acute Myeloid Leukemia in First Remission","display_name":"Personalized Oral Maintenance Therapy with Decitabine/Cedazuridine (ASTX727) Combined with a Molecularly Targeted Agent (Venetoclax, Gilteritinib, Ivosidenib, or Enasidenib) in Acute Myeloid Leukemia in First Remission","publication_year":2024,"publication_date":"2024-11-05","ids":{"openalex":"https://openalex.org/W4405038686","doi":"https://doi.org/10.1182/blood-2024-198928"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2024-198928","doi":"https://doi.org/10.1182/blood-2024-198928","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2024-198928","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060548911","display_name":"Alexandre Bazinet","orcid":"https://orcid.org/0000-0001-5538-4943","observed_orcids":["https://orcid.org/0000-0001-5538-4943"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandre Bazinet","raw_affiliation_strings":["1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035605515","display_name":"Naval Guastad Daver","orcid":"https://orcid.org/0000-0001-7103-373X","observed_orcids":["https://orcid.org/0000-0001-7103-373X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naval Daver","raw_affiliation_strings":["2MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000750846","display_name":"Farhad Ravandi","orcid":"https://orcid.org/0000-0002-7621-377X","observed_orcids":["https://orcid.org/0000-0002-7621-377X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Farhad Ravandi","raw_affiliation_strings":["3Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091492845","display_name":"Nicholas James Short","orcid":"https://orcid.org/0000-0002-2983-2738","observed_orcids":["https://orcid.org/0000-0002-2983-2738"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas J. Short","raw_affiliation_strings":["1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050041791","display_name":"Musa E. Yilmaz","orcid":"https://orcid.org/0000-0002-4498-4895","observed_orcids":["https://orcid.org/0000-0002-4498-4895","https://orcid.org/0000-0001-9557-678X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Musa Yilmaz","raw_affiliation_strings":["1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009316700","display_name":"Maro N. Ohanian","orcid":"https://orcid.org/0000-0002-1689-4470","observed_orcids":["https://orcid.org/0000-0002-1689-4470"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maro Ohanian","raw_affiliation_strings":["1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049134775","display_name":"Jo Ishizawa","orcid":"https://orcid.org/0000-0001-8566-7370","observed_orcids":["https://orcid.org/0000-0001-8566-7370"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jo Ishizawa","raw_affiliation_strings":["4Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075581944","display_name":"Abhishek Maiti","orcid":"https://orcid.org/0000-0001-9043-538X","observed_orcids":["https://orcid.org/0000-0001-9043-538X"]},"institutions":[{"id":"https://openalex.org/I919571938","display_name":"The University of Texas Health Science Center at Houston","ror":"https://ror.org/03gds6c39","country_code":"US","type":"education","lineage":["https://openalex.org/I919571938"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abhishek Maiti","raw_affiliation_strings":["5Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Leukemia, The University of Texas Health Science Center At Houston, Houston, TX","institution_ids":["https://openalex.org/I919571938"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010786159","display_name":"Courtney Denton Dinardo","orcid":"https://orcid.org/0000-0001-9003-0390","observed_orcids":["https://orcid.org/0000-0001-9003-0390"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Courtney D. DiNardo","raw_affiliation_strings":["1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080350639","display_name":"Lucia Mas\u00e1rov\u00e1","orcid":"https://orcid.org/0000-0001-6624-4196","observed_orcids":["https://orcid.org/0000-0001-6624-4196"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lucia Masarova","raw_affiliation_strings":["1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089428686","display_name":"William G. Wierda","orcid":"https://orcid.org/0000-0002-7357-270X","observed_orcids":["https://orcid.org/0000-0002-7357-270X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William G. Wierda","raw_affiliation_strings":["6The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028622482","display_name":"Kelly Sharon Chien","orcid":"https://orcid.org/0000-0001-6024-1613","observed_orcids":["https://orcid.org/0000-0001-6024-1613"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kelly S. Chien","raw_affiliation_strings":["7Department of Leukemia, MD Anderson, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Department of Leukemia, MD Anderson, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049385583","display_name":"Elias Joseph Jabbour","orcid":"https://orcid.org/0000-0003-4465-6119","observed_orcids":["https://orcid.org/0000-0003-4465-6119"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elias Jabbour","raw_affiliation_strings":["6The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085006230","display_name":"Danielle E. Hammond","orcid":"https://orcid.org/0000-0002-6017-2264","observed_orcids":["https://orcid.org/0000-0002-6017-2264"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danielle Hammond","raw_affiliation_strings":["1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015524203","display_name":"Fadi Haddad","orcid":"https://orcid.org/0000-0002-9702-8485","observed_orcids":["https://orcid.org/0000-0002-9702-8485"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fadi G. Haddad","raw_affiliation_strings":["1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029750735","display_name":"Koji Sasaki","orcid":"https://orcid.org/0000-0002-9140-0610","observed_orcids":["https://orcid.org/0000-0002-9140-0610"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Koji Sasaki","raw_affiliation_strings":["1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030606561","display_name":"\u00c1lex Bataller","orcid":"https://orcid.org/0000-0002-6085-2745","observed_orcids":["https://orcid.org/0000-0002-6085-2745"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Bataller","raw_affiliation_strings":["1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011224784","display_name":"Debra Bull-Linderman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debra Bull-Linderman","raw_affiliation_strings":["8Department of Leukemia, MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Department of Leukemia, MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055045706","display_name":"Gautam M. Borthakur","orcid":"https://orcid.org/0000-0001-7679-6453","observed_orcids":["https://orcid.org/0000-0001-7679-6453"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gautam Borthakur","raw_affiliation_strings":["4Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":["1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["9University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020340537","display_name":"Tapan Mahendra Kadia","orcid":"https://orcid.org/0000-0002-9892-9832","observed_orcids":["https://orcid.org/0000-0002-9892-9832"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tapan M. Kadia","raw_affiliation_strings":["1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"144","issue":"Supplement 1","first_page":"4277","last_page":"4277"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8690000176429749},{"id":"https://openalex.org/keywords/astx727","display_name":"ASTX727","score":0.9549999833106995},{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":0.8629999756813049},{"id":"https://openalex.org/keywords/gilteritinib","display_name":"gilteritinib","score":0.9950000047683716},{"id":"https://openalex.org/keywords/enasidenib","display_name":"enasidenib","score":0.968999981880188},{"id":"https://openalex.org/keywords/ivosidenib","display_name":"ivosidenib","score":1.0},{"id":"https://openalex.org/keywords/molecularly-targeted-agents","display_name":"molecularly targeted agents","score":0.6850000023841858},{"id":"https://openalex.org/keywords/first-complete-remission","display_name":"first complete remission","score":0.7820000052452087},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.8259999752044678},{"id":"https://openalex.org/keywords/oral-azacitidine","display_name":"oral azacitidine","score":0.6299999952316284},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.6740000247955322},{"id":"https://openalex.org/keywords/low-dose-cytarabine","display_name":"low-dose cytarabine","score":0.7099999785423279}],"concepts":[{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.9012646675109863},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7030242681503296},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.6706217527389526},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.43249616026878357},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4220839738845825},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.3338780999183655},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.27598968148231506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2074887454509735},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.08684644103050232},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.07498401403427124},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2024-198928","doi":"https://doi.org/10.1182/blood-2024-198928","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2024-198928","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2791038413","https://openalex.org/W3081399433","https://openalex.org/W2899412336","https://openalex.org/W4385514479","https://openalex.org/W3128822483","https://openalex.org/W3031930828","https://openalex.org/W4388673960","https://openalex.org/W2990397977","https://openalex.org/W2012639655","https://openalex.org/W2364732766"],"abstract_inverted_index":{"Background:":[0],"Most":[1],"patients":[2,111,205,342,355,400,428,440,643,665,671,685,691],"with":[3,44,87,115,124,644],"acute":[4],"myeloid":[5],"leukemia":[6],"(AML)":[7],"experience":[8],"relapse":[9],"after":[10,504],"initial":[11,280],"remission,":[12],"especially":[13],"when":[14],"unable":[15,130],"to":[16,90,131,216,307,500,733],"complete":[17,119,132],"standard":[18,133],"consolidation":[19],"strategies":[20],"such":[21],"as":[22,66,101],"high-dose":[23],"cytarabine":[24],"or":[25,49,122,174],"allogeneic":[26],"stem":[27],"cell":[28],"transplantation":[29],"(SCT).":[30],"Ideal":[31],"maintenance":[32,103,699],"therapy":[33,104,134,171,303],"consists":[34],"of":[35,39,47,79,85,96,151,169,218,227,293,329,338,450,455,491,723,737],"the":[36,45,77,236,291,327,336,386,448,515,518,530,546,556,570,580,595,605,621,631,641,663,669,683,689,735],"prolonged":[37],"administration":[38],"effective":[40],"lower":[41],"intensity":[42],"agents":[43],"goal":[46],"delaying":[48],"preventing":[50],"relapse.":[51],"Oral":[52],"azacitidine":[53],"(QUAZAR":[54],"AML-001)":[55],"and":[56,135,186,196,302,321,370,406,419,432,483,507,529,555,579,604,630,704,728],"3-day":[57],"IV":[58,91],"decitabine":[59,86],"(ECOG":[60],"ACRIN":[61],"E2906)":[62],"have":[63,343,356,463],"demonstrated":[64],"efficacy":[65,736],"maintenance.":[67,513,655],"In":[68,541,565,590,615],"this":[69],"phase":[70],"1b":[71],"multi-arm":[72],"study":[73,109],"(NCT05010772),":[74],"we":[75],"evaluated":[76],"combination":[78],"ASTX727":[80,207,228,724],"(decitabine/cedazuridine),":[81],"an":[82,97,279],"oral":[83,98,698],"formulation":[84],"equivalent":[88],"AUC":[89],"decitabine,":[92],"plus":[93,619],"physician":[94,222],"choice":[95],"targeted":[99,697],"agent":[100,173,232],"personalized":[102],"in":[105,117,158,290,347,351,359,363,367,372,398,403,408,415,422,466,489,662,668,682,688,702,711],"AML.":[106,437],"Methods:":[107],"This":[108],"enrolled":[110,157,345,358],"\u2265":[112],"18":[113],"years":[114,391],"AML":[116,703],"first":[118],"remission":[120],"(CR)":[121],"CR":[123],"incomplete":[125],"blood":[126],"count":[127],"recovery":[128],"(CRi)":[129],"not":[136,522],"immediately":[137],"eligible":[138,179],"for":[139,180,235,245,305,385],"SCT.":[140,339],"Patients":[141,161,213],"who":[142,162],"had":[143,163,429,435,441],"received":[144,164,206],"intensive":[145],"induction":[146],"(at":[147],"least":[148,166],"2":[149,567,649],"cycles":[150,168,456,727],"intermediate/high":[152],"dose":[153,287,294],"cytarabine-based":[154,176],"chemotherapy)":[155],"were":[156,178,202,214,299,333,413,476],"cohort":[159,181,283,348,352,388,542,566],"1.":[160,468],"at":[165,335,447,526,538,552,562,576,587,601,612,627,637,647],"3":[167,185,404,423,433],"low-intensity":[170],"(hypomethylating":[172],"low-dose":[175],"regimens)":[177],"2.":[182],"ECOG":[183],"\u2264":[184],"adequate":[187],"bone":[188],"marrow":[189],"function":[190],"(neutrophils":[191],">":[192,198],"0.5":[193],"x":[194,200],"109/L,":[195],"platelets":[197],"50":[199],"109/L)":[201],"required.":[203],"All":[204],"35/100":[208],"mg":[209,243,256,264,272],"PO":[210,249,257,265,273],"on":[211,250,258,266,274,512,654,725],"D1-3.":[212],"assigned":[215],"one":[217],"5":[219,459],"arms":[220,238],"per":[221],"decision.":[223],"Arm":[224,252,260,268],"A":[225,230,592],"consisted":[226],"alone.":[229],"second":[231],"was":[233,313,389,396,659,679],"added":[234],"remaining":[237],"(Arm":[239],"B:":[240],"venetoclax":[241],"400":[242],"(adjusted":[244],"CYP3A4":[246],"inhibitor":[247],"use)":[248],"D1-5;":[251],"C:":[253],"gilteritinib":[254],"120":[255],"D1-28;":[259,267],"D:":[261],"enasidenib":[262],"100":[263],"E:":[269],"ivosidenib":[270],"500":[271],"D1-28).":[275],"Each":[276],"arm":[277,360,364,368,373,591,616],"included":[278,317],"safety":[281],"lead-in":[282],"using":[284],"a":[285],"3+3":[286],"de-escalation":[288],"design":[289],"event":[292],"limiting":[295],"toxicity":[296,501],"(DLT).":[297],"Cycles":[298],"28":[300],"days":[301],"continued":[304],"up":[306],"24":[308],"cycles.":[309,713],"The":[310,375,382,452,469,656,676],"primary":[311],"objective":[312],"safety/tolerability.":[314],"Secondary":[315],"objectives":[316],"overall":[318],"survival":[319,323],"(OS)":[320],"relapse-free":[322],"(RFS)":[324],"starting":[325],"from":[326],"time":[328,337,378,449],"enrollment.":[330,451],"Time-to-event":[331],"endpoints":[332],"censored":[334],"Results:":[340],"31":[341],"been":[344,357,464],"(15":[346],"1,":[349],"16":[350],"2).":[353],"4":[354,426],"A,":[361],"25":[362],"B,":[365],"1":[366,371,416,493,508,527,539,543,553,563,577,588,602,613,628,638],"C,":[369],"D.":[374],"median":[376,383,453,519,531,547,557,571,581,596,606,622,632,657,677],"follow-up":[377,730],"is":[379,458,521,533,549,559,573,583,598,608,624,634,700,709],"15.6":[380],"m.":[381],"age":[384],"full":[387,516],"68":[390],"(33-83).":[392],"ELN":[393],"2022":[394],"risk":[395],"favorable":[397],"13":[399],"(42%),":[401],"intermediate":[402],"(10%),":[405],"adverse":[407,474],"15":[409],"(48%).":[410],"TP53":[411],"mutations":[412],"identified":[414],"(3%)":[417,494],"patient":[418,495],"complex":[420],"cytogenetics":[421],"(10%)":[424,434],"patients.":[425,492],"(13%)":[427],"antecedent":[430],"MDS/MPN":[431],"therapy-related":[436],"9":[438,642],"(29%)":[439],"detectable":[442,645],"measurable":[443],"residual":[444],"disease":[445],"(MRD)":[446],"number":[454],"given":[457],"(1-24).":[460],"No":[461],"DLT's":[462],"noted":[465],"cycle":[467],"most":[470],"common":[471],"grade":[472],"3/4":[473],"events":[475],"neutropenia":[477],"(100%),":[478,480],"leukopenia":[479],"thrombocytopenia":[481,503],"(83%),":[482],"anemia":[484],"(57%).":[485],"Neutropenic":[486],"fever":[487],"occurred":[488,510],"20%":[490],"went":[496],"off":[497],"protocol":[498],"due":[499],"(prolonged":[502],"6":[505],"cycles)":[506],"death":[509],"while":[511,653],"For":[514],"cohort,":[517],"OS":[520,548,572,597,623,658],"reached":[523],"(NR;":[524],"82%":[525],"year)":[528,554,578,603,629],"RFS":[532,558,582,607,633,678],"22.4":[534],"months":[535],"(m)":[536],"(59%":[537],"year).":[540,564,589,614,639],"(intensive":[544],"induction),":[545,569],"NR":[550,560,574,599,625,635,667,687],"(100%":[551,600],"(76%":[561],"(low-intensity":[568],"(69%":[575],"11.7":[584],"m":[585,610,661,681],"(43%":[586],"(ASTX727":[593,618],"alone),":[594],"16.8":[609],"(50%":[611],"B":[617],"venetoclax),":[620],"(78%":[626],"(65%":[636],"Of":[640],"MRD":[646],"enrollment,":[648],"(22%)":[650],"became":[651],"MRD-negative":[652,670,690],"11.3":[660],"MRD-positive":[664,684],"versus":[666,686],"(n=22;":[672],"p":[673],"<":[674,693],"0.01).":[675],"6.6":[680],"(p":[692],"0.001).":[694],"Conclusions:":[695],"Combination":[696],"feasible":[701],"demonstrates":[705],"encouraging":[706],"RFS.":[707],"Myelosuppression":[708],"universal":[710],"subsequent":[712,726],"Prophylactic":[714],"anti-infectives":[715],"are":[716,731],"encouraged.":[717],"Further":[718],"enrollment":[719],"exploring":[720],"dose/schedule":[721],"modifications":[722],"longer":[729],"required":[732],"confirm":[734],"these":[738],"regimens.":[739]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3}],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}